Sramana Mitra: You know, we’ve had several discussions on AI-enabled drug discovery in, towards the end of last year. We have covered AI-enabled drug discovery on our blog quite extensively. It’s an area that I think is super exciting and super promising. Now, the conclusion that was coming out of those discussions was that drug
Sramana Mitra: Software development is getting hugely streamlined, right? The co-pilots are becoming extremely effective. So, you don’t need as many people on the software services side as well. There are a lot of co-pilot products that are getting sold into that business. So, there’s a whole market emerging out of efficiency in the software
Entrepreneur, Angel Investor, and Board Member Raju Reddy discusses his AI investment thesis.